U.S. market Closed. Opens in 5 hours 55 minutes

KRYS | Krystal Biotech, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue50.70MN/AN/AN/AN/A1.03MN/AN/A
Cost of Revenue8.10M4.05M2.77M1.85M974.00KN/AN/AN/A
Gross Profit42.60M-4.05M-2.77M-1.85M-974.00K1.03MN/AN/A
Operating Expenses139.82M120.20M68.28M33.00M22.08M11.92M4.77MN/A
Selling, General & Admin93.39M77.73M40.39M15.06M6.46M4.16M1.56M402.00K
Research & Development46.43M42.46M27.88M17.94M15.62M7.76M3.21M741.00K
Other Operating Expenses15.59M25.00MN/AN/AN/AN/AN/AN/A
Operating Income-97.23M-145.20M-68.28M-33.00M-22.08M-11.92M-4.77M-1.14M
Other Expenses / Income110.12M5.22M-1.29M832.00K2.99M1.03M-3.15M-7.00K
Before Tax Income12.90M-139.97M-69.57M-32.17M-19.09M-10.89M-7.92M-1.15M
Income Tax Expenses1.97M34.05M2.73M1.64M576.14KN/AN/AN/A
Net Income10.93M-139.97M-69.57M-32.17M-19.09M-10.89M-7.92M-1.15M
Interest ExpensesN/A5.22M1.49MN/AN/A1.03M3.15M7.00K
Basic Shares Outstanding27.15M25.49M22.20M18.79M15.90M11.20M5.36M9.64M
Diluted Shares Outstanding27.75M25.49M22.20M18.79M15.90M11.20M5.36M9.64M
EBITDA-92.22M-110.92M-65.31M-31.15M-21.33M-11.78M-4.75M-1.14M
EBITDA Margin-181.90%0.00%0.00%0.00%0.00%-1,146.54%0.00%0.00%
EBIT12.90M-100.71M-65.35M-30.52M-18.51M-9.86M-4.77M-1.14M
EBIT Margin25.44%0.00%0.00%0.00%0.00%-960.27%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙